Singapore to Develop and Produce mRNA Influenza Vaccines to Bolster Pandemic Preparedness
Singapore is actively pursuing the development and production of new mRNA influenza vaccines within its borders, a strategic move aimed at enhancing the nation's pandemic preparedness and building robust vaccine manufacturing capabilities. Health Minister Ong Ye Kung emphasized that this initiative is crucial for Singapore to effectively respond to future pandemics, including potential outbreaks from unknown pathogens like 'Disease X'. The Health Ministry plans to collaborate with organizations such as Hilleman Laboratories, which has its headquarters and manufacturing facility in Singapore, to advance these mRNA vaccine projects. mRNA technology, widely utilized during the COVID-19 pandemic, is favored for its flexibility in development and speed to market, making it an ideal platform for rapidly responding to fast-spreading diseases. The goal is to produce a commonly used vaccine, such as for influenza, during peacetime to maintain and 'keep warm' the manufacturing facilities and expertise. This effort i...